Author name: ZasAdmin

Rise & Refresh: ZAS Corporation’s Inspiring Year-End Retreat to Kuakata

ZAS Corporation Headquarters team wrapped up 2024 with an unforgettable recreation tour to the picturesque beaches of Kuakata. Surrounded by serene sea views, the team embraced moments of relaxation, rejuvenation, and connection. The retreat was packed with exciting activities, including games, strategic discussions, and team-building exercises, fostering collaboration and unity. This year-end getaway not only

Rise & Refresh: ZAS Corporation’s Inspiring Year-End Retreat to Kuakata Read More »

ZAS Corporation Ltd. Partners with LABAID Diagnostics and LABAID Cancer Hospital for Employee Healthcare

ZAS Corporation Ltd. is delighted to announce the signing of a Memorandum of Understanding (MOU) with LABAID Diagnostics and LABAID Cancer Hospital & Super Speciality Centre. This strategic partnership aims to provide employees with access to comprehensive health check-ups and state-of-the-art medical facilities. By joining forces with LABAID, ZAS Corporation reinforces its dedication to fostering

ZAS Corporation Ltd. Partners with LABAID Diagnostics and LABAID Cancer Hospital for Employee Healthcare Read More »

ZAS Corporation Celebrates 19th Anniversary with Team Participation

ZAS Corporation proudly marked its 19th anniversary, celebrating nearly two decades of excellence, innovation, and growth. The milestone event saw enthusiastic participation from the entire team, who came together for a memorable photo session. These group photos, collaged and shared on social media, symbolize the unity and dedication that have been the cornerstone of the

ZAS Corporation Celebrates 19th Anniversary with Team Participation Read More »

ZAS Corporation Secures Trademark for DECA Brand

We are proud to announce that ZAS Corporation Ltd. has officially secured the trademark for our brand DECA. Registered under trademark no. 243264, this certification, effective from January 26, 2020, covers gloves for medical purposes and other products under class 10. This milestone reaffirms our commitment to delivering high-quality healthcare solutions while protecting our brand

ZAS Corporation Secures Trademark for DECA Brand Read More »

ZAS Corporation Obtains Trademark for Protimeal Brand

We are delighted to announce that ZAS Corporation has successfully obtained the trademark for our brand Protimeal. Registered under trademark no. 216979, effective from November 15, 2017, this certification covers all goods under class 30. This achievement highlights our dedication to protecting the integrity of our products and ensuring that Protimeal continues to provide trusted

ZAS Corporation Obtains Trademark for Protimeal Brand Read More »

ZAS Corporation Successfully Launches Celltrion Biosimilars in Bangladesh

We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh, marking a significant milestone in our commitment to advancing healthcare in the nation. This launch represents not just the introduction of new treatments but the beginning of a new era in patient care, driven by innovation and quality. Our launch campaign

ZAS Corporation Successfully Launches Celltrion Biosimilars in Bangladesh Read More »

Productive Meetings & Promising Partnerships in Philippines.

The Philippine business tour proved to be a uniquely successful experience, highlighted by productive meetings and promising partnerships. Enthusiastically anticipating the potential for business expansion in the Philippines. As we depart from this vibrant landscape, we carry with us not only the memories of productive exchanges but also a renewed sense of enthusiasm for the

Productive Meetings & Promising Partnerships in Philippines. Read More »

ZAS Divisional Heads Unite for ‘Towards Tomorrow’ Visioning Session

In a momentous gathering at ZAS, divisional heads came together for an inspiring ‘Towards Tomorrow – A Collective Visioning Session.’ Led by the Chairman and Managing Director, alongside visionary leaders, the event marked a pivotal occasion as the course for future goals was charted. With a shared vision to redefine success and innovation, the leaders

ZAS Divisional Heads Unite for ‘Towards Tomorrow’ Visioning Session Read More »

ZAS Pharma Ltd.’s Managing Director, Md. Zahidul Islam, Spearheads Advancements in Glaucoma Care at the 14th Annual BGS Conference in Vietnam.

In a significant stride towards advancing eye healthcare, Md. Zahidul Islam, the Managing Director of ZAS Pharma Ltd., recently participated in the 14th Annual National Conference of the Bangladesh Glaucoma Society (BGS) held in Vietnam. The event served as a pivotal platform for professionals and experts in the field of ophthalmology to exchange knowledge and

ZAS Pharma Ltd.’s Managing Director, Md. Zahidul Islam, Spearheads Advancements in Glaucoma Care at the 14th Annual BGS Conference in Vietnam. Read More »

Scroll to Top

Send us your query